Article
HIF-1 Signaling in Drug Resistance to Chemotherapy
13 Apr 2014
Abstract excerpt
Activation of hypoxia-inducible factor 1 (HIF-1) signaling is observed in a broad range of human cancers due to tumor hypoxia and epigenetic mechanisms. HIF-1 activation leads to the transcription of a plethora of target genes that promote physiological changes associated with therapeutic resistance, including the inhibition of apoptosis and senescence and the activation of drug efflux and cellular metabolism. As...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
